Avidity Biosciences (NASDAQ:RNA) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Avidity Biosciences missed estimated earnings by 17.14%, reporting an EPS of $-0.82 versus an estimate of $-0.7.
Revenue was up $290.00 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 0.51% increase in the share price the next day.
Here's a look at Avidity Biosciences's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.68 | -0.71 | -0.56 | -0.34 |
| EPS Actual | -0.68 | -0.70 | -0.64 | -0.43 |
| Revenue Estimate | 2.12M | 1.94M | 1.00M | 840.00K |
| Revenue Actual | 2.16M | 2.61M | 2.70M | 2.14M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
